Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response

• Autor(a) principal: Bittar, Cintia [UNESP]
• Data de Publicação: 2010
• Outros Autores: Jardim, Ana Carolina G. [UNESP], Yamasaki, Lilian H. T. [UNESP], de Queiroz, Artur T. L., Carareto, Claudia M. A. [UNESP], Pinho, Joao Renato R., de Carvalho-Mello, Isabel Maria V. G., Rahal, Paula [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1186/1471-2334-10-36; http://hdl.handle.net/11449/21647

Background: The quasispecies nature of HCV may have important implications for viral persistence, pathogenicity and resistance to antiviral agents. The variability of one of the viral proteins, NS5A, is believed to be related to the response to IFN therapy, the standard treatment for infection. In this study we analyzed the quasispecies composition of NS5A protein in patients infected with HCV genotype 3a, before IFN therapy.Methods: Viral RNA was isolated from samples of 12 patients: four sustained virological responders (SVR), four non-responders (NR), and four end-of-treatment responders (ETR). cDNA was synthesized, the NS5A region was amplified and the fragments obtained were cloned. Fifteen clones from each patient were sequenced with eight primers, generating 179 contigs.Results: Higher values for substitution (either synonymous or non-synonymous) and for distance were found in the SVR group. However, the NR group showed relatively more non-synonymous mutations than the other groups, owing to the higher values of dN/dS in complete NS5A and most specific regions. Overall, NS5A protein is undergoing purifying selection, since all dN/dS ratios values are below 0.5.Conclusions: Our study provides an overview of the genetic variability of complete NS5A protein in HCV genotype 3a.